The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place.
Government is expanding prescription coverage for long-acting muscarinic antagonist (LAMAs) inhalers, used in the treatment of Chronic Obstructive Pulmonary Disease. The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place. This will ensure NLPDP beneficiaries have timely access to these inhalers for the treatment of their COPD.
Someone is messing with fire hydrants in Stephenville and police look for the public's help
A man and woman caught with cocaine after traffic stops in Corner Brook and Deer Lake
Corner Brook MHA announces money to develop bike trails and a new PET scanner for hospital
Seniors Advocate says NL seniors are getting poorer while the cost of living keeps going up
Government provides information on benefit check contacts during the postal strike
